Biomedicine & Pharmacotherapy SCIE
國際簡稱：BIOMED PHARMACOTHER 參考譯名：生物醫(yī)學與藥物治療
主要研究方向：醫(yī)學-藥學 預警期刊 審稿周期： 約2月 約7周
《生物醫(yī)學與藥物治療》(Biomedicine & Pharmacotherapy)是一本由Elsevier Masson出版的以醫(yī)學-藥學為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應用學科的最新發(fā)現(xiàn)，旨在促進該學科領(lǐng)域科學信息的快速交流。該期刊是一本未開放期刊。該期刊享有很高的科學聲譽，影響因子不斷增加，發(fā)行量也同樣高。
- 2區(qū) 中科院分區(qū)
- Q1 JCR分區(qū)
- 1743 年發(fā)文量
- 6.9 IF影響因子
- 未開放 是否OA
- 78 H-index
- 1982 創(chuàng)刊年份
- Monthly 出版周期
- Multi-Language 出版語言
Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology.
The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases.
Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents. Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans.
Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers
Biomedicine & Pharmacotherapy期刊信息
- ISSN：0753-3322
- 出版語言：Multi-Language
- 是否OA：未開放
- E-ISSN：1950-6007
- 出版地區(qū)：FRANCE
- 是否預警：是
- 出版商：Elsevier Masson
- 出版周期：Monthly
- 創(chuàng)刊時間：1982
- 開源占比：0.9507
- Gold OA文章占比：96.76%
- OA被引用占比：0.5432...
- 出版國人文章占比：0.56
- 出版撤稿占比：0.0061...
- 研究類文章占比：67.58%
Biomedicine & Pharmacotherapy CiteScore評價數(shù)據(jù)（2024年最新版）
| CiteScore | SJR | SNIP | CiteScore 指數(shù) | ||||||||
| 11.9 | 1.493 | 1.409 |
|
名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標。當年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量 注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。
Biomedicine & Pharmacotherapy中科院評價數(shù)據(jù)
中科院 2023年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 是 | 否 | 醫(yī)學 | 2區(qū) | PHARMACOLOGY & PHARMACY 藥學 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 | 1區(qū) 2區(qū) |
中科院 2022年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 是 | 否 | 醫(yī)學 | 2區(qū) | PHARMACOLOGY & PHARMACY 藥學 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 | 1區(qū) 2區(qū) |
中科院 2021年12月舊的升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 是 | 否 | 醫(yī)學 | 2區(qū) | PHARMACOLOGY & PHARMACY 藥學 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 | 1區(qū) 2區(qū) |
中科院 2021年12月基礎版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 是 | 否 | 醫(yī)學 | 2區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 PHARMACOLOGY & PHARMACY 藥學 | 3區(qū) 2區(qū) |
中科院 2021年12月升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 是 | 否 | 醫(yī)學 | 2區(qū) | PHARMACOLOGY & PHARMACY 藥學 MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 | 1區(qū) 2區(qū) |
中科院 2020年12月舊的升級版
| Top期刊 | 綜述期刊 | 大類學科 | 小類學科 | ||
| 否 | 否 | 醫(yī)學 | 2區(qū) | MEDICINE, RESEARCH & EXPERIMENTAL 醫(yī)學：研究與實驗 PHARMACOLOGY & PHARMACY 藥學 | 2區(qū) 2區(qū) |
Biomedicine & Pharmacotherapy JCR評價數(shù)據(jù)（2023-2024年最新版）
| 按JIF指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科：MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | 21 / 189 |
89.2% |
| 學科：PHARMACOLOGY & PHARMACY | SCIE | Q1 | 15 / 354 |
95.9% |
| 按JCI指標學科分區(qū) | 收錄子集 | 分區(qū) | 排名 | 百分位 |
| 學科：MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | 18 / 189 |
90.74% |
| 學科：PHARMACOLOGY & PHARMACY | SCIE | Q1 | 25 / 354 |
93.08% |
Biomedicine & Pharmacotherapy歷年數(shù)據(jù)統(tǒng)計
影響因子
中科院分區(qū)
Biomedicine & Pharmacotherapy中國學者發(fā)文選摘
-
1、Attenuated WNV-poly(A) exerts a broad-spectrum oncolytic effect by selective virus replication and CD8+T cell-dependent immune response
Author: Liu, Jing; Hu, Yan-Yan; Zhang, Qiu-Yan; Zhang, Ya-Nan; Li, Na; Zhang, Zhe-Rui; Zhan, Shun-Li; Gao, Lei; Deng, Cheng-Lin; Li, Xiao-Dan; Yuan, Shao-Peng; He, Yuan-Qiao; Ye, Han-Qing; Zhang, Bo
Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114094
-
2、Glutathione improves testicular spermatogenesis through inhibiting oxidative stress, mitochondrial damage, and apoptosis induced by copper deposition in mice with Wilson disease
Author: Chen, Kuiyu; Wu, Limin; Liu, Qianzhuo; Tan, Fang; Wang, Luyao; Zhao, Dan; Fang, Xinru; Liu, Xiang; Liu, Jiabo; Han, Hui
Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114107
-
3、Arctium lappa (Burdock): Insights from ethnopharmacology potential, chemical constituents, clinical studies, pharmacological utility and nanomedicine
Author: Yosri, Nermeen; Alsharif, Sultan M.; Xiao, Jianbo; Musharraf, Syed G.; Zhao, Chao; Saeed, Aamer; Gao, Ruichang; Said, Noha S.; Di Minno, Alessandro; Daglia, Maria; Guo, Zhiming; Khalifa, Shaden A. M.; El-Seedi, Hesham R.
Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114104
-
4、A novel inhibitor of PGK1 suppresses the aerobic glycolysis and proliferation of hepatocellular carcinoma
Author: Li, Mingfeng; Zhang, Aotong; Qi, Xin; Yu, Rilei; Li, Jing
Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114115
-
5、Sodium tanshinone IIA sulfonate protects against hyperhomocysteine-induced vascular endothelial injury via activation of NNMT/SIRT1-mediated NRF2/HO-1 and AKT/MAPKs signaling in human umbilical vascular endothelial cells
Author: Zhou, Zhong-Yan; Shi, Wen-Ting; Zhang, Jing; Zhao, Wai-Rong; Xiao, Ying; Zhang, Kai-Yu; Ma, Jie; Tang, Jing-Yi; Wang, Yu
Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114137
-
6、Attenuation of hyperglycemia-associated dyslipidemic, oxidative, cognitive, and inflammatory crises via modulation of neuronal ChEs/NF-kappa B/COX-2/NOx, and hepatorenal functional deficits by the Tridax procumbens extract
Author: Hogan, Itam Ako; Kuo, Yu-Cheng; Abubakar, Asmau N.; Lawal, Bashir; Agboola, Abdulhakeem R.; Lukman, Halimat Yusuf; Onikanni, Sunday Amos; Olawale, Femi; Fadaka, Adewale Oluwaseun; Ibrahim, Yunusa O.; Babalola, Shukurat B.; Batiha, Gaber El -Saber; Albogami, Sarah M.; Alorabi, Mohammed; De Waard, Michel; Huang, Hsu-Shan
Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114114
-
7、Exercise induced meteorin-like protects chondrocytes against inflammation and pyroptosis in osteoarthritis by inhibiting PI3K/Akt/NF-kappa B and NLRP3/caspase-1/GSDMD signaling
Author: Liu, Jiabao; Jia, Shuangshuo; Yang, Yue; Piao, Longhuan; Wang, Ziyuan; Jin, Zhuangzhuang; Bai, Lunhao
Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114118
-
8、Revealment study on the regulation of lipid metabolism by Lingguizhugan Decoction in heart failure treatment based on integrated lipidomics and proteomics
Author: Wang, Xu; Gao, Yanhua; Zhang, Jia; Zhang, Huaxing; Sun, Shuo; Su, Suwen; Kong, Dezhi; Wang, Qiao
Journal: BIOMEDICINE & PHARMACOTHERAPY. 2023; Vol. 158, Issue , pp. -. DOI: 10.1016/j.biopha.2022.114066
Biomedicine & Pharmacotherapy同類期刊
-
公共衛(wèi)生前沿
Frontiers In Public Health
中科院 3區(qū) JCR Q2
-
藥理學前沿
Frontiers In Pharmacology
中科院 2區(qū) JCR Q1
-
生物醫(yī)學與藥物治療
Biomedicine & Pharmacotherapy
中科院 2區(qū) JCR Q1
-
探索腫瘤學
Discover Oncology
中科院 4區(qū) JCR Q2
-
Bmc精神病學
Bmc Psychiatry
中科院 2區(qū) JCR Q2
-
Bmc神經(jīng)病學
Bmc Neurology
中科院 3區(qū) JCR Q3
-
材料化學雜志 B
Journal Of Materials Chemistry B
中科院 3區(qū) JCR Q1
-
美康
Medcomm
中科院 3區(qū) JCR Q1
免責聲明
若用戶需要出版服務，請聯(lián)系出版商：ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 23 RUE LINOIS, PARIS, FRANCE, 75724。